Join the club for FREE to access the whole archive and other member benefits.

Christian Angermayer

Founder of Apeiron Investment Group and Presight Capital

Christian Angermayer is an entrepreneur, investor and film enthusiast. He is the founder of Apeiron Investment Group and Presight Capital. Apeiron focuses on Financial Services (especially fintech and crypto assets), Technology, Life Sciences, Media & Entertainment and Real Estate. Christian has created, co-founded and invested in numerous successful companies.

In 2000, Christian co-founded Ribopharma (original patents for RNAi technology) which merged with US peer Alnylam in 2003 and subsequently went public. With his biotech company atai Life Sciences, Christian has the ambitious goal to enable people to live healthier and happier lives.

Passionate about the arts and film, Christian has (executive) produced 14 feature films including critically acclaimed movies like Filth, Aspern Papers and Hector and the Search for Happiness.

Visit website: https://christian-angermayer.de/

 christian-angermayer

 C_Angermayer

See also: Company Apeiron Investment Group - Investment company focused on life sciences, deep technology, and financial services

Details last updated 21-May-2021

Christian Angermayer is also referenced in the following:

Rejuveron Age Better Live Longer Symposium

10-May-2022

Symposium about healthy living organized by Rejuveron (FREE)

Christian Angermayer News

Rejuveron raises $20 million for Endogena to advance treatment for eye diseases

CISION PR Newswire - 31-Dec-2021

Funds to develop regenerative therapies for retinitis pigmentosa and advanced age-related macular degeneration

Read more...

A proactive step for next generation drug discovery by Cambrian Biopharma

Longevity Technology - 26-Oct-2021

Novel business approach helps people to live longer with good health

Read more...

Blackrock Neurotech receives $10m funding from Peter Thiel

CNBC - 19-May-2021

New competitor for Neuralink's brain implant, streamlining solution for neurological disorders

Read more...